We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Arthritis Research U.K., MS Society to award $10 million in research grants

Arthritis Research U.K., MS Society to award $10 million in research grants

September 6, 2013
CenterWatch Staff

Arthritis Research U.K. and the MS Societyare partnering three research councils in the second stage of a nationwide project, which will see $10 million made available to researchers in stem cell and tissue engineering research.

Regenerative medicine is the process of replacing or regenerating damaged or diseased tissue so normal function can be restored without joint replacement surgery.

The $39 million U.K. Regenerative Medicine Platform (UKRMP) aims to address the challenges associated with translating scientific discoveries into patient benefit in the field of regenerative medicine.

The first stage led to the creation of several interdisciplinary research centers set up to address some of the scientific questions that block new therapies from being translated into new treatments for patients.

Now the research councils are inviting research proposals to establish collaborative research groupings to build on the success of the initial funding and stimulate research with the potential to become new regenerative medicine treatments.

“We hope that by being involved in this initiative, we will stimulate a number of opportunities to bring together leading scientists to tackle the necessary issues to bring these therapies into patients,” said Professor Alan Silman, medical director of Arthritis Research U.K.

Arthritis Research U.K. also has formed a collaboration with a European research body with the Dutch Arthritis Foundation, Rheumafonds. This collaboration follows recognition that there is some overlap between U.K. and Dutch research groups in the field of regenerative medicine and osteoarthritis.

Rheumafonds are now also involved in the UKRMP initiative, and will contribute financially to grant applications that can show added value for English and Dutch researchers working collaboratively.

Upcoming Events

  • 16Dec

    Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

Featured Products

  • Regenerative-medicine-steps-to-accelerate-development-pdf

    Regenerative Medicine: Steps to Accelerate Development — PDF

  • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

    Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

Featured Stories

  • Ich_logo

    ICH Overhauls 22-Year-Old Clinical Studies Guideline

  • Survey_chart2019

    Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

  • China-360x240

    U.S. Tops List of Trial Startups With China Making Progress in Phase 1

  • Phoneapp-360x240

    Device Apps Present Unique Risks in Trials

New!

2019 Site Survey Reports

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing